RELATED CONTENT
The American Society for Radiation Oncology (ASTRO) released a report that recommends critical areas of biological basic research that would most advance the clinical benefits of radiation oncology.
November 19, 2013 
October 03, 2013 
The North Shore-LIJ Health System Department of Radiation Medicine presented a study to evaluate the reliability of different systems used by caregivers to assess toxicity for patients receiving radiation therapy at the 55th Annual Meeting of the American Society of Therapeutic Radiation Oncology (ASTRO).
October 02, 2013 
Patients receiving radiotherapy (RT) for cancers in the pelvic region can experience diarrhea, a negative side effect of radiation treatment. Sulfasalazine, an oral tablet used to treat inflammation of the bowels, had been shown in a past trial of 31 patients to decrease diarrhea during pelvic RT. Sulfasalazine does not reduce diarrhea, according to research presented today at the American Society of Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study also determined that the medication might be associated with a higher risk of diarrhea than placebo.
October 01, 2013 
Limiting the amount of radiation absorbed in the hippocampal portion of the brain during whole-brain radiotherapy (WBRT) for brain metastases preserves memory function in patients for up to six months after treatment according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
September 30, 2013 An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting. The study also suggests that lung cancer patients who received intensity modulated radiation therapy (IMRT) reported less decline in their QOL compared to those receiving three-dimensional conformal radiation therapy (3-D CRT).
September 25, 2013 Proton therapy, an external beam radiotherapy in which protons deliver precise radiation doses to a tumor and spare healthy organs and tissues, is cost-effective in treating medulloblastomas, fast-growing brain tumors that mainly affect children, when compared to standard photon radiation therapy, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 55th Annual Meeting.
September 22, 2013 The American Society for Radiation Oncology (ASTRO) highlighted the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO’s 55th Annual Meeting, September 22-25, 2013, in Atlanta.
September 22, 2013 CT texture analysis of primary tumors may be a potential imaging biomarker in localized esophageal cancer following neoadjuvant chemotherapy, according to research being presented at the 2013 Cancer Imaging and Radiation Therapy Symposium. This Symposium is sponsored by the American Society for Radiation Oncology (ASTRO) and the Radiological Society of North America (RSNA).
February 13, 2013 At the 2012 annual meeting of the American Society for Radiology Oncology (ASTRO) in Boston, Siemens Healthcare highlighted its technology to optimize and accurately image for radiation therapy treatment planning and follow-up.
November 08, 2012